Alkem Laboratories Limited (BOM:539523)
4,880.00
-81.65 (-1.65%)
At close: Mar 28, 2025
Alkem Laboratories Statistics
Total Valuation
BOM:539523 has a market cap or net worth of INR 578.16 billion. The enterprise value is 574.23 billion.
Market Cap | 578.16B |
Enterprise Value | 574.23B |
Important Dates
The next estimated earnings date is Friday, May 16, 2025.
Earnings Date | May 16, 2025 |
Ex-Dividend Date | Feb 14, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.01% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 37.27M |
Valuation Ratios
The trailing PE ratio is 26.85.
PE Ratio | 26.85 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 5.28 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 26.67 |
EV / Sales | 4.50 |
EV / EBITDA | 23.02 |
EV / EBIT | 25.91 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.12 |
Debt / EBITDA | 0.59 |
Debt / FCF | n/a |
Interest Coverage | 25.15 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 11.06% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 7.32M |
Profits Per Employee | 1.24M |
Employee Count | 17,432 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.22% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -1.22% |
50-Day Moving Average | 4,868.47 |
200-Day Moving Average | 5,445.93 |
Relative Strength Index (RSI) | 48.16 |
Average Volume (20 Days) | 1,627 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:539523 had revenue of INR 127.57 billion and earned 21.53 billion in profits. Earnings per share was 180.09.
Revenue | 127.57B |
Gross Profit | 80.38B |
Operating Income | 22.16B |
Pretax Income | 24.98B |
Net Income | 21.53B |
EBITDA | 24.67B |
EBIT | 22.16B |
Earnings Per Share (EPS) | 180.09 |
Balance Sheet
The company has 22.89 billion in cash and 14.78 billion in debt, giving a net cash position of 8.11 billion.
Cash & Cash Equivalents | 22.89B |
Total Debt | 14.78B |
Net Cash | 8.11B |
Net Cash Per Share | n/a |
Equity (Book Value) | 119.10B |
Book Value Per Share | 961.30 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 63.01%, with operating and profit margins of 17.37% and 16.88%.
Gross Margin | 63.01% |
Operating Margin | 17.37% |
Pretax Margin | 19.58% |
Profit Margin | 16.88% |
EBITDA Margin | 19.34% |
EBIT Margin | 17.37% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 42.00, which amounts to a dividend yield of 0.86%.
Dividend Per Share | 42.00 |
Dividend Yield | 0.86% |
Dividend Growth (YoY) | -6.67% |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.01% |
Shareholder Yield | 0.87% |
Earnings Yield | 3.72% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |